[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].

  title={[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].},
  author={Novel Coronavirus Pneumonia Emergency Response Epidemiol Team},
  journal={Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi},
  volume={41 2},
  • Novel Coronavirus Pneumonia Emergency Response Epidemiol Team
  • Published 2020
  • Medicine
  • Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Objective: An outbreak of 2019 novel coronavirus diseases (COVID-19) in Wuhan, China has spread quickly nationwide. Here, we report results of a descriptive, exploratory analysis of all cases diagnosed as of February 11, 2020. Methods: All COVID-19 cases reported through February 11, 2020 were extracted from China's Infectious Disease Information System. Analyses included: 1) summary of patient characteristics; 2) examination of age distributions and sex ratios; 3) calculation of case fatality… Expand
1,975 Citations

Paper Mentions

Observational Clinical Trial
The new coronavirus SARS-CoV-2, causes the COVID-19 infection, which showed a form of neurovirulence involving the Central and peripheral Nervous Systems [Baig et al, 2020]. In a… Expand
ConditionsNeurologic Manifestations
InterventionDevice, Diagnostic Test, Genetic
Observational Patient Registry Clinical Trial
The reason the investigators want to do this research; Especially after Covid-19 infection, no research has been found on functional status in the long term. Therefore, in our study… Expand
ConditionsCorona Virus Infection, Covid19
Interventional Clinical Trial
COVID-19 Viral Global Pandemic resulting in post-infection pulmonary damage, including Fibrotic Lung Disease due to inflammatory and reactive protein secretions damaging pulmonary… Expand
ConditionsCOPD, Coronavirus Infection, Idiopathic Pulmonary Fibrosis, (+3 more)
InterventionDevice, Drug, Procedure
Interventional Clinical Trial
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib in the treatment of patients with COVID-19 severe pneumonia.  
ConditionsARDS, Human, COVID
Epidemiology of COVID-19 Among Children in China
  • 1,531
  • PDF
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China
  • 30


Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside
  • 15
Does Early Childhood Vaccination Protect Against COVID-19?
  • 22
Identification of RT-PCR-Negative Asymptomatic COVID-19 Patients via Serological Testing
  • 5
Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan.
  • 130
Early Detection and Assessment of Covid-19
  • 7
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
  • 692